Self-management with verapamil or metoprolol for atrial fibrillation
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether a self-management approach using either verapamil or metoprolol can help control your atrial fibrillation symptoms. It includes a smartphone app to track your heart rhythm and guide treatment changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have paroxysmal atrial fibrillation (AF that comes and goes) confirmed by an ECG
- You have had at least 2 episodes of symptomatic AF in the last 4 months
- You are willing to use a smartphone (for the SMART sub-study)
- You are not taking certain heart medications or have conditions that make verapamil or metoprolol unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a mobile education program for people with atrial fibrillation. If you have an Android smartphone and meet the other criteria, you may be able to join and learn how to manage your condition better.
This study tests whether using a smart watch to track your heart rhythm and guide treatment decisions can help manage paroxysmal atrial fibrillation (an irregular heartbeat that comes and goes). Researchers will monitor your heart activity continuously through wearable devices to see if this approach improves outcomes.
This study tests a new medication, AP31969, to control heart rhythm in people with atrial fibrillation. It compares the drug to a placebo to see if it can reduce how often AF episodes happen over time.
This trial uses a smartphone and smartwatch to track your atrial fibrillation over time. It aims to understand how the condition progresses and the risk of blood clots.
This trial compares two common heart medicines (verapamil and metoprolol) to see which works better for people with a fast, irregular heartbeat called atrial fibrillation. If you come to the Emergency Department with a heart rate of 110 or more and are stable, you may be able to join.
This trial studies whether sending heart rhythm recordings from a phone (using the KardiaMobile ECG device) can improve health care use and patient experience for people with atrial fibrillation. It may help your care team monitor you more smoothly—if you meet the study requirements.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.